Stock comparison
RESMED INC is 21.5x more valuable than NovoCure Ltd by market capitalization ($33.10 B vs $1.54 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RMD is larger
RESMED INC is 21.5x more valuable than NovoCure Ltd by market capitalization ($33.10 B vs $1.54 B).
Market value leader
RMD
RESMED INC is 21.5x more valuable than NovoCure Ltd by market capitalization ($33.10 B vs $1.54 B).
Revenue leader
RMD
NVCR: $655.35M vs RMD: $5.65B.
Profit leader
RMD
NVCR: -$136.23M vs RMD: $1.52B.
Margin leader
RMD
NVCR: -20.8% vs RMD: 26.9% net margin.
| Metric | NVCR | RMD |
|---|---|---|
| Market cap | $1.54 B | $33.10 B |
| US-listed rank | #2276 | #432 |
| Revenue (latest FY) | $655.35M | $5.65B |
| Net income (latest FY) | -$136.23M | $1.52B |
| Net margin | -20.8% | 26.9% |
| P/E (trailing FY) | - | 21.7x |
| SEC filings | 1,138 | 2,518 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
RESMED INC is 21.5x more valuable than NovoCure Ltd by market capitalization ($33.10 B vs $1.54 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while RESMED INC reported $5.65B.
Full pages: NovoCure Ltd and RESMED INC, or browse the full rankings.